S. ChaichanK. SawanyawisuthP. LimpawattanaP. WatcharenwongJ. ChindaprasirtV. ChotmongkolK. KongbunkiatP. ChattakulY. SittichanbunchaS. KhamsaiFaculty of Medicine, Khon Kaen UniversityKhon Kaen UniversityFaculty of Medicine, Ramathibodi Hospital, Mahidol University2020-03-262020-03-262020-01-01Journal of the Medical Association of Thailand. Vol.103, No.1 (2020), 68-72012522082-s2.0-85079039104https://repository.li.mahidol.ac.th/handle/20.500.14594/53862© 2020 JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND. Objective: To evaluate whether or not self-sampling for human papilloma virus (HPV) infection in developing countries is acceptable and sensitive. Materials and Methods: A sub-group analysis of a previous review published by Madzima et al. The primary outcome of the present study was either acceptability or sensitivity of HPV self-sampling compared with the Pap test. Results: There were 43 relevant studies, four of which were conducted in developing countries. Three studies assessed the acceptability of the self-sampling method and one evaluated its sensitivity. There were 21,965 eligible participants. The acceptability rate of self-sampling was 82 to 98%, and its sensitivity was 4.2 times better than cytology in cases of invasive cervical cancer. Conclusion: Self-sampling for HPV is highly acceptable and may be more sensitive than cervical cytology in developing countries.Mahidol UniversityMedicineRoles of self-sampling for human papillomavirus in developing countriesArticleSCOPUS